Vanguard Capital Management
CRVO icon

Vanguard Capital Management’s CervoMed CRVO Stock Holding History

Vanguard Capital Management’s Portfolio CRVO Stock Details CRVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$980K Hold
316,202
– – ﹤0.01% 3597
2026
Q1 		$1.25M Buy
+316,202
New +$1.65M ﹤0.01% 3500

Other funds holding CRVO

WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BAM
Byrne Asset Management Kingston, New Jersey $185M AUM 41.05% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $8.3B AUM 27.66% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
TDC
Thompson Davis & Co Richmond, Virginia $167M AUM 33.45% 1-Year Est. Return
SAI
Savvy Advisors Inc New York $4.71B AUM 25.36% 1-Year Est. Return

Vanguard Capital Management's CRVO Position: Q2 2026 in Review

Vanguard Capital Management held its CervoMed (CRVO) position steady in Q2 2026 at 316,202 shares worth $980K. The position accounts for ﹤0.01% of the portfolio, ranked #3597.

Vanguard Capital Management first reported a position in CRVO in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.25M in Q1 2026. 37 funds tracked by Wall St. Rank hold CRVO as of Q2 2026.

  • Vanguard Capital Management held 316,202 shares of CervoMed worth $980K as of Q2 2026.
  • Vanguard Capital Management left its CervoMed share count unchanged in Q2 2026.
  • CervoMed made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #3597 holding.
  • Vanguard Capital Management first reported a position in CervoMed in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Capital Management's CervoMed position peaked at $1.25M in Q1 2026.
  • 37 funds tracked by Wall St. Rank held CervoMed as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.